Do-Coop Drug Delivery Systems, Drug Development for the Pharma Industry
May 7, 2007: Do-Coop presented and exhibited Neowater technology at the Bio 2007 Annual International Convention in Boston

Do-Coop presented Neowater technology at the Business Forum (May 9th, 11:15am, Room B, Drug Delivery Session) and also exhibited during the Bio 2007 Annual International Convention in Boston, MA, on May 6-9, 2007.
Do-Coop presented Neowater technology at the Business Forum (May 9th, 11:15am, Room B, Drug Delivery Session) and also exhibited during the Bio 2007 Annual International Convention in Boston, MA, on May 6-9, 2007.

 

Drug development | Enzyme Stabilization | Protein Stabilization | Pharma – Pharmaceutical companies  
 About Us   |    Neowater   |    Technology   |    Pharma   |    Biotech   |    Pharma Overview   |    Business   |    Posters / Presentations   |    Media Center   |    Business Opportunities   |    Recent Collaborations   |    Biotech Overview   |    Understanding Water   |    Video Gallery   |    Do-Coop IP / Patents   |    Company Overview   |    Advisory Board   |    Management   |    News & PR   |    Pharma Applications   |    Business Contact   |    Publications   |    Articles   |    Biotech Applications   |   Contact us   |   Drug Articles

All rights reserved to Do-Coop Technologies Ltd which developed a novel drug delivery system that offers a revolutionary solution for Drug development challenges. Do-Coop's proprietary water based nanotechnology which is branded as NeowaterŪ offers an added value to Hydrophobic compounds, drug stability, drug bioavailability, small molecule solubilization, drug efficacy, Antibody stabilization, Protein stabilization, Enzyme stabilization, Stem cell viability, Stem cell growth, Cell line viability, transfection, , Stem cells media and Cell line cryopreservation. With Do-Coop Technologies the formulation of drugs is a fast, high quality and time saving process. | Drug development RSS Feed

Encountered with a broken link or other Website malfunction? Please contact the Site Administrator
This site is best viewed on Internet explorer version 5.5 or higher